September 17: The Week in Cancer News
An immunotherapy combination continues to be effective in treating kidney cancer patients, and more news of the week from Cancer Today.
Progress Against Cancer
An immunotherapy combination continues to be effective in treating kidney cancer patients, and more news of the week from Cancer Today.
Blood cancer patients are highly vulnerable to COVID-19 infection. Now mounting evidence suggests they may be also among the least protected by vaccines. Blood Cancer Discovery, a journal of the American Association for Cancer Research (AACR), has recently published studies investigating the...
9/11 first responders’ cancer survival compares favorably to the general population, and more news of the week from Cancer Today.
Cancer is often described as a disease of old age, but over 15,000 children are diagnosed with cancer each year in the United States. While pediatric cancers tend to have higher survival rates than...
High-poverty counties in the United States may lag far behind wealthier counties in eliminating cervical cancer, a study published in the AACR journal Cancer Epidemiology, Biomarkers & Prevention found.
Researchers investigate how antibiotics might increase the risk of colon cancer, and other news of the week selected by the staff of Cancer Today magazine.
A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
What if a machine could “think” like a doctor and diagnose and treat a disease? This is one of the long-term goals for the field of artificial intelligence (AI). In a session co-sponsored by the American Association for Cancer Research...
Regular exercise can help mitigate cognitive problems associated with chemotherapy, and more news of the week from Cancer Today.
Glioblastoma is an aggressive form of brain cancer. Less than 5 percent of patients diagnosed with this cancer type will survive for five years or more. Glioblastoma is notoriously difficult to treat, and new avenues...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 49,000 members worldwide drive progress against cancer.
Donate Now